PRECIGEN, INC. — Director's Dealing 2019

Jan 22, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: INTREXON CORP (XON)
CIK: 0001356090
Period of Report: 2018-12-28

Reporting Person: Ares Trading S.A. (10% Owner)
Reporting Person: Merck KGaA (10% Owner)
Reporting Person: MERCK SERONO S.A. (10% Owner)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	20640119	Direct

Footnotes

F1: In addition to the securities reported herein, Ares Trading S.A. holds a Convertible Note in the original principal amount of $25,000,000 which is convertible at any time into Common Stock of the Issuer, subject to limited exceptions, at a conversion price equal to (a) the volume weighted-average price per share of the Common Stock on the Nasdaq Stock Market for the consecutive ten trading days immediately prior to the conversion date as reported by Bloomberg, L.P. or (b) if converted in connection with a qualified public offering by the Issuer, the lowest price per share paid by a purchaser in such qualified public offering. The Convertible Note and shares of Issuer Common Stock issuable thereunder, which are not reported as beneficially owned herein pursuant to Rule 16a-1(c)(6) promulgated under the Securities Exchange Act of 1934, are more fully described in the Schedule 13G filed by the Reporting Persons on January 7, 2019.